Fekrirad Zahra, Gharedaghi Milad, Saadatpour Fatemeh, Molabashi Zahra Asghari, Rezayof Ameneh, Korourian Alireza, Soleimani Masoud, Arefian Ehsan
Department of Microbiology, School of Biology, College of Science, University of Tehran, Tehran, Iran.
Department of Biology, Faculty of Basic Sciences, Shahed University, Tehran, Iran.
Heliyon. 2024 Aug 29;10(17):e37041. doi: 10.1016/j.heliyon.2024.e37041. eCollection 2024 Sep 15.
Glioblastoma (GBM), a grade IV brain tumor, presents a severe challenge in treatment and eradication due to its high genetic variability and the existence of stem-like cells with self-renewal potential. Conventional therapies fall short of preventing recurrence and fail to extend the median survival of patients significantly. However, the emergence of gene therapy, which has recently obtained significant clinical outcomes, brings hope. It has the potential to be a suitable strategy for the treatment of GBM. Notably, microRNAs (miRNAs) have been noticed as critical players in the development and progress of GBM. The combined usage of hsa-miR-34a and Cytosine Deaminase (CD) suicide gene and 5-fluorocytosine (5FC) prodrug caused cytotoxicity against U87MG Glioma cells . The apoptosis and cell cycle arrest rates were measured by flow cytometry. The lentiviral vector generated overexpression of CD/miR-34a in the presence of 5FC significantly promoted apoptosis and caused cell cycle arrest in U87MG cells. The expression level of the and genes, target genes of hsa-miR-34a, was examined by quantitative real-time PCR. The treatment led to a substantial downregulation of and genes while elevating the expression levels of and genes compared to the scrambled control. The hsa-miR-34a hindered the proliferation of GBM cancer cells and elevated apoptosis through the P53-miR-34a-Bcl2 axis. The CD suicide gene with 5FC treatment demonstrated similar results to miR-34a in the apoptosis, cell cycle, and real-time assays. The combination of CD and miR-34a produced a synergistic effect. anti-GBM efficacy evaluation in rats bearing intracranial C6 Glioma cells revealed a remarkable induction of apoptosis and a significant inhibition of tumor growth compared with the scrambled control. The simultaneous use of CD/miR-34a with 5FC almost entirely suppressed tumor growth in rat models. The combined application of hsa-miR-34a and CD suicide gene against GBM tumors led to significant induction of apoptosis in U87MG cells and a considerable reduction in tumor growth .
胶质母细胞瘤(GBM)是一种IV级脑肿瘤,由于其高度的基因变异性以及存在具有自我更新潜力的干细胞样细胞,在治疗和根除方面面临严峻挑战。传统疗法在预防复发方面效果不佳,也未能显著延长患者的中位生存期。然而,最近取得显著临床疗效的基因疗法的出现带来了希望。它有可能成为治疗GBM的合适策略。值得注意的是,微小RNA(miRNA)已被视为GBM发生和发展的关键因素。人源miR-34a与胞嘧啶脱氨酶(CD)自杀基因和5-氟胞嘧啶(5FC)前药联合使用对U87MG胶质瘤细胞产生了细胞毒性。通过流式细胞术测量凋亡率和细胞周期阻滞率。在5FC存在的情况下,慢病毒载体使CD/miR-34a过表达,显著促进了U87MG细胞的凋亡并导致细胞周期阻滞。通过定量实时PCR检测人源miR-34a的靶基因 和 基因的表达水平。与乱序对照相比,该治疗导致 和 基因显著下调,同时提高了 和 基因的表达水平。人源miR-34a通过P53-miR-34a-Bcl2轴阻碍GBM癌细胞的增殖并提高凋亡率。CD自杀基因与5FC治疗在凋亡、细胞周期和实时检测中显示出与miR-34a相似的结果。CD和miR-34a的联合产生了协同效应。对携带颅内C6胶质瘤细胞的大鼠进行的抗GBM疗效评估显示,与乱序对照相比,凋亡显著诱导,肿瘤生长受到显著抑制。在大鼠模型中,同时使用CD/miR-34a和5FC几乎完全抑制了肿瘤生长。人源miR-34a和CD自杀基因联合应用于GBM肿瘤导致U87MG细胞中凋亡显著诱导,肿瘤生长显著减少。